Kengo Fukuzawa

Oita Red Cross Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. Kengo Fukuzawa is a leading figure in hepatobiliary and pancreatic surgery, with a focused expertise in advancing minimally invasive liver surgery (MILS). His major contributions center on challenging long-standing surgical conventions to improve patient outcomes. Dr. Fukuzawa is the principal investigator of a landmark multicenter randomized controlled trial that rigorously evaluates the feasibility of non-routine abdominal drainage after MILS, a practice that could significantly reduce postoperative complications and hospital stays. This work, detailed in a 2025 study protocol, has already garnered attention within the surgical community. His research has been cited over 1,000 times, reflecting his influence in reshaping postoperative care protocols. Dr. Fukuzawa’s notable achievements include pioneering techniques in laparoscopic and robotic hepatectomy, and his work is instrumental in moving the field toward evidence-based, patient-centered surgical practices. For students and researchers, his career exemplifies how rigorous clinical trials can directly transform surgical standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of non-routine abdominal drainage for minimally invasive liver surgery: study protocol for a multicenter randomized controlled clinical trial
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Oita Red Cross Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago